SnagRx vs Start Willow: Price, Shipping, and Transparency Compared
Comparing SnagRx vs Start Willow? Quick verdict: SnagRx is the lower-cost option on an annual plan with price lock and named pharmacies, while Start Willow is pricier but markets faster delivery and a direct-pay model that emphasizes branded-comparable formulations.
See SnagRx semaglutide pricing and plan details
How they differ at a glance
Both providers deliver compounded GLP-1 medications without insurance and without membership fees, and both note that compounded medications are not FDA-approved finished products. The most distinctive differences are price and pricing structure, delivery speed and guarantee, the way each positions medications relative to branded products, and how much provider transparency is presented about pharmacies and clinician networks.
Price and pricing model
SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month as 12-month plan rates, with month-to-month equivalents at $99 and $149. SnagRx states the 12-month figures are the annual plan rates and that the rate is locked flat at every dose for the life of treatment. Start Willow lists pricing from $249 for the first month and $299/month ongoing; the captured evidence states Start Willow is priced at $249 for the first month and $299/month ongoing.
View Start Willow semaglutide pricing
Delivery speed and shipping commitments
SnagRx states approved orders ship next-day via UPS or FedEx in temperature-controlled packaging and claims next-day delivery, with clinician review typically within five hours. Start Willow guarantees delivery in 3 days or less from its licensed pharmacy network and also advertises same day prescriptions and free 2-Day shipping in captured evidence. The two providers thus present different delivery promises: SnagRx emphasizes next-day shipping after approval, Start Willow guarantees delivery within three days.
Medication positioning and formulation
SnagRx sells compounded semaglutide and compounded tirzepatide only and explicitly says it offers compounded medications, not branded Ozempic, Wegovy, Mounjaro, or Zepbound. Start Willow offers compounded medications described as comparable to Ozempic and tirzepatide and markets a customized compounded semaglutide formulation created in collaboration with a Willow doctor. Both sources include the regulatory note that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality.
Transparency: pharmacies, clinicians, and guarantees
SnagRx names its US 503A partner pharmacies and its clinician network (OpenLoop Health), states LegitScript certification, and advertises a full refund if a prescription is declined plus a 6-month weight-loss guarantee with terms. Start Willow highlights an online clinician review and a Willow Care Team but captured evidence does not list named pharmacies or a stated outcome guarantee comparable to SnagRx. Start Willow emphasizes bypassing insurance pre-authorization and no membership fees.
Side-by-side comparison
| Criteria | SnagRx | Start Willow |
|---|---|---|
| Starting price | From $69/month semaglutide (12-month plan) | From $249 per Month (first month) |
| Ongoing price | Month-to-month $99/month; 12-month $69/month | $299/month ongoing |
| Price model | 12-month plan rate locks flat at every dose for life of treatment | Direct-pay; first month $249 then $299 ongoing |
| Medication type | Compounded semaglutide and tirzepatide only | Compounded formulations described as comparable to Ozempic and tirzepatide |
| Shipping commitment | States next-day shipping after approval; next-day UPS/FedEx | Guarantees delivery in 3 days or less; captured evidence notes free 2-Day shipping |
| Transparency | Names four US 503A pharmacies and OpenLoop Health clinician network; states LegitScript certification | No named pharmacies in captured evidence; emphasizes clinician collaboration and Willow Care Team |
| Guarantees | Full refund if prescription declined; 6-month weight-loss guarantee (terms apply) | No comparable outcome guarantee supplied in captured evidence |
Clinical access and eligibility notes
Both platforms use online intake and clinician review to determine eligibility. SnagRx states an OpenLoop clinician typically reviews intake within five hours and always within 24 and that the clinician network covers 48 states. Start Willow operates with a licensed clinician review and frames its direct-pay model as a way to avoid insurance prior-authorization delays; captured evidence highlights its suitability for patients denied GLP-1 coverage.
Check SnagRx clinician review and enrollment process
What neither source supplies
Neither source provides FDA approval for the compounded finished products; both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. No comparative efficacy or long-term outcome data between SnagRx and Start Willow is supplied in the captured evidence.
Final thoughts on SnagRx vs Start Willow
For straightforward cost-driven access with a 12-month price lock, SnagRx advertises the lowest annual plan rates and names its pharmacy and clinician partners. For patients prioritizing a branded-comparable framing and a guaranteed 3-day delivery window with direct-pay simplicity, Start Willow positions itself on convenience despite higher ongoing price.
Choose SnagRx if you want the lowest advertised 12-month price with a locked flat rate, named US 503A pharmacies, and the clinician network claim. Choose Start Willow if you value a direct-pay route that markets medications comparable to Ozempic and tirzepatide plus a delivery guarantee of 3 days or less.
Primary keyword: SnagRx vs Start Willow
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →